These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1133764

  • 21. Sodium sensitive active transport of bretylium into adrenergic neurons for the development of blockade in rabbit ileum.
    Hosotani T, Misu Y.
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):235-45. PubMed ID: 879907
    [Abstract] [Full Text] [Related]

  • 22. Class III antiarrhythmic effects of ceruloplasmin on rat heart.
    Atanasiu R, Gouin L, Mateescu MA, Cardinal R, Nadeau R.
    Can J Physiol Pharmacol; 1996 Jun; 74(6):652-6. PubMed ID: 8909775
    [Abstract] [Full Text] [Related]

  • 23. Reduction in norepinephrine content of sympathetic neuroeffector organs by alpha adrenergic antagonists and nerve stimulation: evidence for presynaptic control of sympathetic transmitter release in intact animal.
    Wakade AR, Wakade TD.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):287-92. PubMed ID: 6141280
    [Abstract] [Full Text] [Related]

  • 24. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
    Rochetaing A, Chapon C, Marescaux L, Le Bouil A, Furber A, Kreher P.
    Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
    [Abstract] [Full Text] [Related]

  • 25. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.
    Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, Klein MS.
    J Clin Invest; 1978 Sep; 62(3):546-53. PubMed ID: 690185
    [Abstract] [Full Text] [Related]

  • 26. Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
    Arbilla S, Perec CJ, Stefano FJ.
    Eur J Pharmacol; 1980 Jan 25; 61(2):147-57. PubMed ID: 7353586
    [Abstract] [Full Text] [Related]

  • 27. [Presynaptic adrenergic mechanisms of action of oxilofrin].
    Jacquot C, Rapin JR.
    Arzneimittelforschung; 1980 Jan 25; 30(5):776-9. PubMed ID: 7190419
    [Abstract] [Full Text] [Related]

  • 28. [Effect of anoxia on the excitability of the canine ventricular muscle (author's transl)].
    Imura H, Kato K.
    Jpn Circ J; 1975 Sep 25; 39(9):1069-81. PubMed ID: 1195511
    [Abstract] [Full Text] [Related]

  • 29. The effect of bretylium on endogenous and newly-synthesized noradrenaline in the microsomal fraction of rat heart.
    Abbs ET, Pycock CJ.
    Br J Pharmacol; 1974 Apr 25; 50(4):606-8. PubMed ID: 4447863
    [Abstract] [Full Text] [Related]

  • 30. The effects of bretylium on C fibre excitation and noradrenaline release by acetylcholine and electrical stimulation.
    Davey MJ, Hayden ML, Scholfield PC.
    Br J Pharmacol; 1968 Oct 25; 34(2):377-87. PubMed ID: 5687592
    [Abstract] [Full Text] [Related]

  • 31. Antifibrillatory action of bretylium: role of the sympathetic nervous system.
    Kopia GA, Lucchesi BR.
    Pharmacology; 1987 Oct 25; 34(1):37-47. PubMed ID: 3575413
    [Abstract] [Full Text] [Related]

  • 32. Interaction of bretylium tosylate with rat cardiac muscarinic receptors. Possible pharmacological relevance to antiarrhythmic action.
    Schreiber G, Friedman M, Sokolovsky M.
    Circ Res; 1984 Nov 25; 55(5):653-9. PubMed ID: 6488487
    [Abstract] [Full Text] [Related]

  • 33. Competitive inhibition of acetylcholinesterase by bretylium: possible mechanism for its induction of norepinephrine release.
    Schreiber G, Sokolovsky M.
    J Cardiovasc Pharmacol; 1985 Nov 25; 7(6):1065-8. PubMed ID: 2418289
    [Abstract] [Full Text] [Related]

  • 34. Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.
    Abbs ET, Robertson MI.
    Br J Pharmacol; 1970 Apr 25; 38(4):776-91. PubMed ID: 5441790
    [Abstract] [Full Text] [Related]

  • 35. The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity.
    Papp JG, Vaughan Williams EM.
    Br J Pharmacol; 1969 Oct 25; 37(2):380-90. PubMed ID: 5348427
    [Abstract] [Full Text] [Related]

  • 36. Effects of chronic bretylium treatment on the sympathetic neuron and the smooth musculature of the rat.
    Murdoch SD, Evans BK, Heath JW, Hill CE, Burnstock G.
    Eur J Pharmacol; 1977 Jun 01; 43(3):225-35. PubMed ID: 872877
    [Abstract] [Full Text] [Related]

  • 37. Tissue distribution of [14C]bretylium tosylate in rats.
    Yacobi A, Kamath BL, Lai CM, Stampfli HF.
    J Pharm Sci; 1983 May 01; 72(5):556-9. PubMed ID: 6864505
    [Abstract] [Full Text] [Related]

  • 38. Concerning the role of the amine pump of the adrenergic innervation of rabbit aorta in sustaining the neuron blockade produced by bethanindine and bretylium.
    Maxwell RA, Eckhardt SB.
    Blood Vessels; 1975 May 01; 12(3):166-80. PubMed ID: 1164562
    [Abstract] [Full Text] [Related]

  • 39. Direct studies on the disappearance of the transmitter and changes in the uptake-storage mechanisms of degenerating adrenergic nerves.
    Malmfors T, Sachs C.
    Acta Physiol Scand; 1965 Jul 01; 64(3):211-23. PubMed ID: 5855019
    [No Abstract] [Full Text] [Related]

  • 40. Bretylium and the supersensitivity to exogenous noradrenaline after sympathetic denervation studied in the conscious rat.
    Lundberg D.
    Acta Physiol Scand; 1972 Apr 01; 84(4):500-5. PubMed ID: 5028459
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.